HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 47.10
-0.45 (-0.95%)
Jul 9, 2026, 1:23 PM CST
HeXun Biosciences Market Cap
HeXun Biosciences has a market cap or net worth of 2.16 billion as of July 9, 2026. Its market cap has decreased by -37.58% in one year.
Market Cap
2.16B
Enterprise Value
1.69B
Revenue
293.23M
Ranking
n/a
PE Ratio
19.34
Stock Price
47.10
Market Cap Chart
Since September 7, 2023, HeXun Biosciences's market cap has decreased from 4.16B to 2.16B, a decrease of -48.01%. That is a compound annual growth rate of -20.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 2.16B | -25.40% |
| Dec 31, 2025 | 2.90B | -6.67% |
| Dec 31, 2024 | 3.11B | 4.17% |
| Dec 29, 2023 | 2.98B | -28.32% |
| Sep 7, 2023 | 4.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intech Biopharm | 2.93B |
| BRIM Biotechnology | 2.92B |
| GlycoNex Incorporation | 2.89B |
| 3D Global Biotech | 2.62B |
| Syngen Biotech | 2.37B |
| Taiwan Bio Therapeutics | 2.29B |
| Sunhawk Vision Biotech | 2.17B |
| G&E Herbal Biotechnology | 2.16B |